Study results showed a small and marginally significant decrease in the LVEF of 2% in the cisplatin-gemcitabine arm and a larger significant decrease in the LVEF of 7% in the epirubicin-gemcitabine arm.
← all excerpts
Echocardiography and cardiac biomarkers in patients with non-small cell lung cancer treated with platinum-based chemotherapy.
1
—
—